Literature DB >> 27939026

Depression and associated variables in people over 50 years in Spain.

Cristina Portellano-Ortiz1, Josep Garre-Olmo2, Laia Calvó-Perxas3, Josep Lluís Conde-Sala4.   

Abstract

INTRODUCTION: Depression is a common and disabling psychiatric disorder in adulthood and is associated with higher mortality and functional disability.
OBJECTIVES: To determine the association between clinical and sociodemographic variables with depression in a sample of people over 50 years old living in Spain, and compare the prevalence of depression with the other Survey of Health, Ageing and Retirement (SHARE) countries.
MATERIAL AND METHODS: There were 5,830 participants in the Spanish sample of the Wave 5, 2013, of SHARE. Tools used: EURO-D (Depression) and CASP-12 (Quality of Life). STATISTICAL ANALYSIS: Bivariate, and binary logistic.
RESULTS: The variables associated with depression in the binary logistic regression (EURO-D ≥4) were poor self-perceived physical health (OR=13.34; 95% CI: 9.74-18.27), having more than 2 difficulties in Activities of Daily Living (ADL) (OR=4.46; 95% CI: 3.13-6.34) and female gender (OR=2.16; 95% CI: 1.83-2.56). Depression was more common among participants with Alzheimer (76.4%), emotional disorders (73.9%), Parkinson (57.4%), hip fracture (55.4%), and rheumatism (50.9%). Compared with other European countries, Spain had a percentage of people with depression (29.3%) that was higher than the European average (27.9%).
CONCLUSIONS: The most important variables associated with depression were poor perceived physical health, presence of difficulties in ADL, and female gender.
Copyright © 2016 SEP y SEPB. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Ageing; Depresión; Depression; EURO-D; Envejecimiento; Physical health; SHARE; Salud física

Mesh:

Year:  2016        PMID: 27939026     DOI: 10.1016/j.rpsm.2016.10.003

Source DB:  PubMed          Journal:  Rev Psiquiatr Salud Ment (Engl Ed)        ISSN: 2173-5050


  6 in total

1.  Depression in the Elderly. Consensus Statement of the Spanish Psychogeriatric Association.

Authors:  Luis Agüera-Ortiz; María Dolores Claver-Martín; María Dolores Franco-Fernández; Jorge López-Álvarez; Manuel Martín-Carrasco; María Isabel Ramos-García; Manuel Sánchez-Pérez
Journal:  Front Psychiatry       Date:  2020-05-20       Impact factor: 4.157

2.  Factors related to depression in older adults during the COVID-19 pandemic in two coastal regions of Peru: An analytical cross-sectional study.

Authors:  Elena de Jesús Quispe Sáenz; José Fernando Salvador-Carrillo; Oriana Rivera-Lozada; Cesar Antonio Bonilla Asalde
Journal:  F1000Res       Date:  2021-09-22

3.  Physical Activity and Prevalence of Depression and Antidepressants in the Spanish Population.

Authors:  Carmen Galán-Arroyo; Damián Pereira-Payo; Jorge Rojo-Ramos; Miguel A Hernández-Mocholí; Eugenio Merellano-Navarro; Jorge Pérez-Gómez; Ángel Denche-Zamorano; Jose Carmelo Adsuar
Journal:  Healthcare (Basel)       Date:  2022-02-12

4.  Benefits of STRENOLD Program on Health-Related Quality of Life in Adults Aged 60 Years or Older. In Common Sport Study.

Authors:  Irimia Mollinedo-Cardalda; Adriana López Rodríguez; Manuela Ferreira; José María Cancela-Carral
Journal:  Int J Environ Res Public Health       Date:  2021-03-21       Impact factor: 3.390

5.  The Impact of Depression Symptoms in Patients with Parkinson's Disease: A Novel Case-Control Investigation.

Authors:  Ana María Jiménez-Cebrián; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; Daniel López-López; César Calvo-Lobo; Patricia Palomo-López; Carlos Romero-Morales; Emmanuel Navarro-Flores
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

6.  Increased Odds for Depression and Antidepressant Use in the Inactive Spanish Population.

Authors:  Carmen Galán-Arroyo; Damián Pereira-Payo; Jorge Rojo-Ramos; Miguel A Hernández-Mocholí; Eugenio Merellano-Navarro; Jorge Pérez-Gómez; Ángel Denche-Zamorano; Jose Carmelo Adsuar
Journal:  Int J Environ Res Public Health       Date:  2022-02-28       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.